Exact Mass: 307.1936

Exact Mass Matches: 307.1936

Found 43 metabolites which its exact mass value is equals to given mass value 307.1936, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Benzatropine

(1R,3R,5S)-3-(diphenylmethoxy)-8-methyl-8-azabicyclo[3.2.1]octane

C21H25NO (307.1936)


Benzotropine is a centrally-acting, antimuscarinic agent used as an adjunct in the treatment of Parkinsons disease. It may also be used to treat extrapyramidal reactions, such as dystonia and Parkinsonism, caused by antipsychotics (e.g. phenothiazines). Symptoms of Parkinsons disease and extrapyramidal reactions arise from decreases in dopaminergic activity which creates an imbalance between dopaminergic and cholinergic activity. Anticholinergic therapy is thought to aid in restoring this balance leading to relief of symptoms. In addition to its anticholinergic effects, benztropine also inhibits the reuptake of dopamine at nerve terminals via the dopamine transporter. Benzotropine also produces antagonistic effects at the histamine H1 receptor. N - Nervous system > N04 - Anti-parkinson drugs > N04A - Anticholinergic agents > N04AC - Ethers of tropine or tropine derivatives D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018765 - Dopamine Uptake Inhibitors D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents D049990 - Membrane Transport Modulators

   

DTAB

Dodecyltrimethylammonium bromide

C15H34BrN (307.1874)


D013501 - Surface-Active Agents > D003902 - Detergents

   

m344

4-(Dimethylamino)-n-[7-(hydroxyamino)-7-oxoheptyl]benzamide

C16H25N3O3 (307.1896)


D004791 - Enzyme Inhibitors > D056572 - Histone Deacetylase Inhibitors

   

Hydroxyterbinafine

(5E)-2,2-dimethyl-7-[methyl(naphthalen-1-ylmethyl)amino]hept-5-en-3-yn-1-ol

C21H25NO (307.1936)


Hydroxyterbinafine is a metabolite of terbinafine. Terbinafine hydrochloride is a synthetic allylamine antifungal from Novartis. It is highly lipophilic in nature and tends to accumulate in skin, nails, and fatty tissues. (Wikipedia)

   

Benztropinum

3-(diphenylmethoxy)-8-methyl-8-azabicyclo[3.2.1]octane

C21H25NO (307.1936)


   

Malarborein

Malarborein

C21H25NO (307.1936)


   

N-Caffeoylspermidine

N-Caffeoylspermidine

C16H25N3O3 (307.1896)


   

5-Hepten-3-yn-1-ol, 2,2-dimethyl-7-[methyl(1-naphthalenylmethyl)amino]-, (E)-

5-Hepten-3-yn-1-ol, 2,2-dimethyl-7-[methyl(1-naphthalenylmethyl)amino]-, (E)-

C21H25NO (307.1936)


   

M 344

4-(dimethylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]-benzamide

C16H25N3O3 (307.1896)


   

4-(Octyloxy)-4-biphenylcarbonitrile

4-(Octyloxy)-4-biphenylcarbonitrile

C21H25NO (307.1936)


   
   
   

2-(1,1-Diethoxymethyl)pyridine-3-boronic acid pinacol ester

2-(1,1-Diethoxymethyl)pyridine-3-boronic acid pinacol ester

C16H26BNO4 (307.1955)


   

9-(6-methoxynaphthalen-2-yl)-3-azaspiro[5.5]undec-9-ene

9-(6-methoxynaphthalen-2-yl)-3-azaspiro[5.5]undec-9-ene

C21H25NO (307.1936)


   

16-bromo-1,1,1-trideuteriohexadecane

16-bromo-1,1,1-trideuteriohexadecane

C16H30BrD3 (307.1954)


   

DI-N-BUTYL N,N-DIETHYLCARBAMOYLMETHYLPHOSPHONATE

DI-N-BUTYL N,N-DIETHYLCARBAMOYLMETHYLPHOSPHONATE

C14H30NO4P (307.1912)


   

n-methoxymethylaza-18-crown-6, 96

n-methoxymethylaza-18-crown-6, 96

C14H29NO6 (307.1995)


   

1H-Pyrrolo[2,3-b]pyridin-5-amine, 4-fluoro-1-[tris(1-methylethyl)silyl]-

1H-Pyrrolo[2,3-b]pyridin-5-amine, 4-fluoro-1-[tris(1-methylethyl)silyl]-

C16H26FN3Si (307.188)


   

2-(2-(BENZYLOXY)-5-(TERT-BUTYL)PHENYL)-2-METHYLPROPANENITRILE

2-(2-(BENZYLOXY)-5-(TERT-BUTYL)PHENYL)-2-METHYLPROPANENITRILE

C21H25NO (307.1936)


   

tert-butyl 4-(5-amino-2-methoxyphenyl)piperazine-1-carboxylate

tert-butyl 4-(5-amino-2-methoxyphenyl)piperazine-1-carboxylate

C16H25N3O3 (307.1896)


   

1-Boc-4-(((3-Aminopyridin-2-yl)oxy)methyl)piperidine

1-Boc-4-(((3-Aminopyridin-2-yl)oxy)methyl)piperidine

C16H25N3O3 (307.1896)


   

2-[[[2-[2-(Dimethylamino)ethyl-Ethyl-Amino]-2-Oxidanylidene-Ethyl]amino]methyl]pyridine-4-Carboxamide

2-[[[2-[2-(Dimethylamino)ethyl-Ethyl-Amino]-2-Oxidanylidene-Ethyl]amino]methyl]pyridine-4-Carboxamide

C15H25N5O2 (307.2008)


   

3,5-Dimethyl-2,6-bis(4-methylphenyl)piperidin-4-one

3,5-Dimethyl-2,6-bis(4-methylphenyl)piperidin-4-one

C21H25NO (307.1936)


   

L-Alanyl-N-[(1s,2r)-1-Benzyl-2-Hydroxypropyl]-L-Alaninamide

L-Alanyl-N-[(1s,2r)-1-Benzyl-2-Hydroxypropyl]-L-Alaninamide

C16H25N3O3 (307.1896)


   

ML-236C carboxylate

ML-236C carboxylate

C18H27O4- (307.1909)


   

(2R,3R)-8-amino-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2R,3R)-8-amino-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C16H25N3O3 (307.1896)


   

(2R,3R)-10-amino-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2R,3R)-10-amino-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C16H25N3O3 (307.1896)


   

(2R,3S)-10-amino-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2R,3S)-10-amino-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C16H25N3O3 (307.1896)


   

(2R,3S)-10-amino-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2R,3S)-10-amino-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C16H25N3O3 (307.1896)


   

(2S,3S)-10-amino-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2S,3S)-10-amino-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C16H25N3O3 (307.1896)


   

(2R,3R)-8-amino-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2R,3R)-8-amino-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C16H25N3O3 (307.1896)


   

(2S,3S)-8-amino-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2S,3S)-8-amino-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C16H25N3O3 (307.1896)


   

(2S,3S)-8-amino-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2S,3S)-8-amino-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C16H25N3O3 (307.1896)


   

(2S,3S)-10-amino-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2S,3S)-10-amino-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C16H25N3O3 (307.1896)


   

(2R,3R)-10-amino-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2R,3R)-10-amino-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C16H25N3O3 (307.1896)


   

(2S,3R)-10-amino-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2S,3R)-10-amino-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C16H25N3O3 (307.1896)


   

(2S,3R)-10-amino-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

(2S,3R)-10-amino-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-1,5-benzoxazocin-6-one

C16H25N3O3 (307.1896)


   

(E)-N-[3-(4-aminobutylamino)propyl]-3-(3,4-dihydroxyphenyl)prop-2-enamide

(E)-N-[3-(4-aminobutylamino)propyl]-3-(3,4-dihydroxyphenyl)prop-2-enamide

C16H25N3O3 (307.1896)


   

Benzatropine

Benzatropine

C21H25NO (307.1936)


   

Cogentin

Benztropine

C21H25NO (307.1936)


N - Nervous system > N04 - Anti-parkinson drugs > N04A - Anticholinergic agents > N04AC - Ethers of tropine or tropine derivatives D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018765 - Dopamine Uptake Inhibitors D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents D049990 - Membrane Transport Modulators

   

3-(diphenylmethoxy)-8-methyl-8-azabicyclo[3.2.1]octane

3-(diphenylmethoxy)-8-methyl-8-azabicyclo[3.2.1]octane

C21H25NO (307.1936)


   

Hydroxy Terbinafine

Hydroxy Terbinafine

C21H25NO (307.1936)


   

(2z,4e)-n-(2-{[(3s)-2-hydroxy-3,4,5,6-tetrahydropyridin-3-yl]-c-hydroxycarbonimidoyl}ethyl)-6-methylhepta-2,4-dienimidic acid

(2z,4e)-n-(2-{[(3s)-2-hydroxy-3,4,5,6-tetrahydropyridin-3-yl]-c-hydroxycarbonimidoyl}ethyl)-6-methylhepta-2,4-dienimidic acid

C16H25N3O3 (307.1896)